Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
ChemicalsPesticide

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2034245

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 2034245

Antifungal Agents Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 207 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global antifungal agents market is steadily evolving as fungal infections become a growing public health concern worldwide. These infections range from mild superficial conditions to severe invasive diseases that can be life-threatening, particularly among immunocompromised individuals. The increasing burden of chronic illnesses, expanding elderly population, and rising number of patients undergoing chemotherapy or organ transplants are significantly contributing to the demand for antifungal therapies. As healthcare systems focus more on infection control and disease prevention, antifungal agents are gaining increased importance in clinical treatment protocols.

Market Insights

The antifungal agents market is estimated to reach US$ 17.6 billion in 2026 and is projected to grow to US$ 24 billion by 2033, registering a CAGR of 4.50% during the forecast period. This growth trajectory reflects consistent demand across both developed and emerging regions. The market is supported by a strong pipeline of antifungal drugs and ongoing innovations aimed at improving drug efficacy and minimizing adverse effects. Increasing healthcare spending and the expansion of pharmaceutical manufacturing capabilities are further supporting market growth.

Market Drivers

The rise in fungal infections is a key factor driving the antifungal agents market. Opportunistic infections are becoming more common due to weakened immune systems caused by diseases such as diabetes, cancer, and HIV/AIDS. Additionally, prolonged hospital stays and the widespread use of invasive medical procedures have increased the risk of hospital-acquired fungal infections.

Another major driver is the advancement in antifungal drug development. Pharmaceutical companies are investing heavily in research to introduce new drug classes and formulations that address drug resistance and improve patient compliance. Enhanced diagnostic capabilities are also enabling early detection of fungal infections, leading to timely treatment and better outcomes.

Furthermore, growing awareness among healthcare professionals and patients about fungal infections is encouraging the adoption of antifungal therapies. Government initiatives to control infectious diseases are also playing a supportive role in market expansion.

Business Opportunity

The antifungal agents market offers numerous growth opportunities for industry participants. The development of next-generation antifungal drugs with improved safety and efficacy profiles is expected to create significant value. There is also increasing interest in combination therapies that can provide broader spectrum coverage and reduce resistance.

Emerging economies present untapped potential due to their large patient populations and improving healthcare infrastructure. Rising disposable incomes and better access to healthcare services are enabling more patients to seek treatment for fungal infections. Companies expanding their presence in these regions can benefit from high growth prospects.

The expansion of online pharmacies is another key opportunity, as it enhances accessibility and convenience for patients. Digital health platforms and telemedicine services are further supporting the distribution and management of antifungal treatments.

Region Analysis

North America continues to lead the antifungal agents market due to its advanced healthcare system, high awareness levels, and strong presence of major pharmaceutical companies such as Pfizer Inc. and Merck & Co., Inc.. The region also benefits from extensive research and development activities and favorable regulatory frameworks.

Europe holds a significant share of the market, driven by rising cases of fungal infections and a well-established healthcare infrastructure. Countries including Germany, France, and the United Kingdom are key contributors to regional growth.

Asia Pacific is expected to witness the fastest growth during the forecast period. Factors such as increasing healthcare expenditure, growing awareness about infectious diseases, and expanding pharmaceutical industries are driving market expansion. Nations such as India and China are emerging as important markets due to their large populations and improving healthcare access.

Latin America and the Middle East & Africa are also showing gradual growth, supported by advancements in healthcare systems and rising focus on disease management. However, limited access to advanced treatments and lower healthcare budgets may pose challenges in these regions.

Key Players

The competitive landscape of the antifungal agents market includes several leading pharmaceutical companies focusing on innovation and expansion strategies. Key players include:

  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Bayer AG
  • Sanofi
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Gilead Sciences, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.

These companies are actively investing in research and development, forming strategic alliances, and expanding their geographic reach to strengthen their market presence.

Market Segmentation

By Drug Class

  • Azoles
  • Echinocandins
  • Polyenes
  • Allylamines
  • Others

By Route of Administration

  • Oral
  • Topical
  • Intravenous

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End User

  • Hospitals
  • Clinics
  • Homecare Settings

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Antifungal Agents Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Antifungal Agents Market Outlook, 2020 - 2033

  • 3.1. Global Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 3.1.1. Azoles
    • 3.1.2. Echinocandins
    • 3.1.3. Polyenes
    • 3.1.4. Allylamines
    • 3.1.5. Others
  • 3.2. Global Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 3.2.1. Oral
    • 3.2.2. Topical
    • 3.2.3. Intravenous
  • 3.3. Global Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 3.3.1. Hospital Pharmacies
    • 3.3.2. Retail Pharmacies
    • 3.3.3. Online Pharmacies
  • 3.4. Global Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 3.4.1. Hospitals
    • 3.4.2. Clinics
    • 3.4.3. Homecare Settings
  • 3.5. Global Antifungal Agents Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Antifungal Agents Market Outlook, 2020 - 2033

  • 4.1. North America Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 4.1.1. Azoles
    • 4.1.2. Echinocandins
    • 4.1.3. Polyenes
    • 4.1.4. Allylamines
    • 4.1.5. Others
  • 4.2. North America Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 4.2.1. Oral
    • 4.2.2. Topical
    • 4.2.3. Intravenous
  • 4.3. North America Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 4.3.1. Hospital Pharmacies
    • 4.3.2. Retail Pharmacies
    • 4.3.3. Online Pharmacies
  • 4.4. North America Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 4.4.1. Hospitals
    • 4.4.2. Clinics
    • 4.4.3. Homecare Settings
  • 4.5. North America Antifungal Agents Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.5.1. U.S. Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 4.5.2. U.S. Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 4.5.3. U.S. Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 4.5.4. U.S. Antifungal Agents Market Outlook, by End User, 2020-2033
    • 4.5.5. Canada Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 4.5.6. Canada Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 4.5.7. Canada Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 4.5.8. Canada Antifungal Agents Market Outlook, by End User, 2020-2033
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Antifungal Agents Market Outlook, 2020 - 2033

  • 5.1. Europe Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 5.1.1. Azoles
    • 5.1.2. Echinocandins
    • 5.1.3. Polyenes
    • 5.1.4. Allylamines
    • 5.1.5. Others
  • 5.2. Europe Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 5.2.1. Oral
    • 5.2.2. Topical
    • 5.2.3. Intravenous
  • 5.3. Europe Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 5.3.1. Hospital Pharmacies
    • 5.3.2. Retail Pharmacies
    • 5.3.3. Online Pharmacies
  • 5.4. Europe Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 5.4.1. Hospitals
    • 5.4.2. Clinics
    • 5.4.3. Homecare Settings
  • 5.5. Europe Antifungal Agents Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.5.1. Germany Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.2. Germany Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.3. Germany Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.4. Germany Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.5. Italy Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.6. Italy Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.7. Italy Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.8. Italy Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.9. France Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.10. France Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.11. France Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.12. France Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.13. U.K. Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.14. U.K. Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.15. U.K. Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.16. U.K. Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.17. Spain Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.18. Spain Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.19. Spain Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.20. Spain Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.21. Russia Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.22. Russia Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.23. Russia Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.24. Russia Antifungal Agents Market Outlook, by End User, 2020-2033
    • 5.5.25. Rest of Europe Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 5.5.26. Rest of Europe Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 5.5.27. Rest of Europe Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 5.5.28. Rest of Europe Antifungal Agents Market Outlook, by End User, 2020-2033
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Antifungal Agents Market Outlook, 2020 - 2033

  • 6.1. Asia Pacific Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 6.1.1. Azoles
    • 6.1.2. Echinocandins
    • 6.1.3. Polyenes
    • 6.1.4. Allylamines
    • 6.1.5. Others
  • 6.2. Asia Pacific Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 6.2.1. Oral
    • 6.2.2. Topical
    • 6.2.3. Intravenous
  • 6.3. Asia Pacific Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 6.3.1. Hospital Pharmacies
    • 6.3.2. Retail Pharmacies
    • 6.3.3. Online Pharmacies
  • 6.4. Asia Pacific Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Homecare Settings
  • 6.5. Asia Pacific Antifungal Agents Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.5.1. China Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.2. China Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.3. China Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.4. China Antifungal Agents Market Outlook, by End User, 2020-2033
    • 6.5.5. Japan Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.6. Japan Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.7. Japan Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.8. Japan Antifungal Agents Market Outlook, by End User, 2020-2033
    • 6.5.9. South Korea Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.10. South Korea Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.11. South Korea Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.12. South Korea Antifungal Agents Market Outlook, by End User, 2020-2033
    • 6.5.13. India Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.14. India Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.15. India Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.16. India Antifungal Agents Market Outlook, by End User, 2020-2033
    • 6.5.17. Southeast Asia Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.18. Southeast Asia Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.19. Southeast Asia Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.20. Southeast Asia Antifungal Agents Market Outlook, by End User, 2020-2033
    • 6.5.21. Rest of SAO Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 6.5.22. Rest of SAO Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 6.5.23. Rest of SAO Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 6.5.24. Rest of SAO Antifungal Agents Market Outlook, by End User, 2020-2033
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Antifungal Agents Market Outlook, 2020 - 2033

  • 7.1. Latin America Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 7.1.1. Azoles
    • 7.1.2. Echinocandins
    • 7.1.3. Polyenes
    • 7.1.4. Allylamines
    • 7.1.5. Others
  • 7.2. Latin America Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 7.2.1. Oral
    • 7.2.2. Topical
    • 7.2.3. Intravenous
  • 7.3. Latin America Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 7.3.1. Hospital Pharmacies
    • 7.3.2. Retail Pharmacies
    • 7.3.3. Online Pharmacies
  • 7.4. Latin America Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 7.4.1. Hospitals
    • 7.4.2. Clinics
    • 7.4.3. Homecare Settings
  • 7.5. Latin America Antifungal Agents Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.5.1. Brazil Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 7.5.2. Brazil Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 7.5.3. Brazil Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 7.5.4. Brazil Antifungal Agents Market Outlook, by End User, 2020-2033
    • 7.5.5. Mexico Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 7.5.6. Mexico Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 7.5.7. Mexico Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 7.5.8. Mexico Antifungal Agents Market Outlook, by End User, 2020-2033
    • 7.5.9. Argentina Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 7.5.10. Argentina Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 7.5.11. Argentina Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 7.5.12. Argentina Antifungal Agents Market Outlook, by End User, 2020-2033
    • 7.5.13. Rest of LATAM Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 7.5.14. Rest of LATAM Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 7.5.15. Rest of LATAM Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 7.5.16. Rest of LATAM Antifungal Agents Market Outlook, by End User, 2020-2033
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Antifungal Agents Market Outlook, 2020 - 2033

  • 8.1. Middle East & Africa Antifungal Agents Market Outlook, by Drug Class, Value (US$ Bn), 2020-2033
    • 8.1.1. Azoles
    • 8.1.2. Echinocandins
    • 8.1.3. Polyenes
    • 8.1.4. Allylamines
    • 8.1.5. Others
  • 8.2. Middle East & Africa Antifungal Agents Market Outlook, by Route of Administration, Value (US$ Bn), 2020-2033
    • 8.2.1. Oral
    • 8.2.2. Topical
    • 8.2.3. Intravenous
  • 8.3. Middle East & Africa Antifungal Agents Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Middle East & Africa Antifungal Agents Market Outlook, by End User, Value (US$ Bn), 2020-2033
    • 8.4.1. Hospitals
    • 8.4.2. Clinics
    • 8.4.3. Homecare Settings
  • 8.5. Middle East & Africa Antifungal Agents Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.5.1. GCC Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 8.5.2. GCC Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 8.5.3. GCC Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 8.5.4. GCC Antifungal Agents Market Outlook, by End User, 2020-2033
    • 8.5.5. South Africa Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 8.5.6. South Africa Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 8.5.7. South Africa Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 8.5.8. South Africa Antifungal Agents Market Outlook, by End User, 2020-2033
    • 8.5.9. Egypt Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 8.5.10. Egypt Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 8.5.11. Egypt Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 8.5.12. Egypt Antifungal Agents Market Outlook, by End User, 2020-2033
    • 8.5.13. Nigeria Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 8.5.14. Nigeria Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 8.5.15. Nigeria Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 8.5.16. Nigeria Antifungal Agents Market Outlook, by End User, 2020-2033
    • 8.5.17. Rest of Middle East Antifungal Agents Market Outlook, by Drug Class, 2020-2033
    • 8.5.18. Rest of Middle East Antifungal Agents Market Outlook, by Route of Administration, 2020-2033
    • 8.5.19. Rest of Middle East Antifungal Agents Market Outlook, by Distribution Channel, 2020-2033
    • 8.5.20. Rest of Middle East Antifungal Agents Market Outlook, by End User, 2020-2033
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Pfizer Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Novartis AG
    • 9.4.3. Merck & Co., Inc.
    • 9.4.4. GlaxoSmithKline plc
    • 9.4.5. Bayer AG
    • 9.4.6. Sanofi
    • 9.4.7. Abbott Laboratories
    • 9.4.8. Astellas Pharma Inc.
    • 9.4.9. Gilead Sciences, Inc.
    • 9.4.10. Teva Pharmaceutical Industries Ltd.
    • 9.4.11. Viatris Inc.
    • 9.4.12. Sun Pharmaceutical Industries Ltd.
    • 9.4.13. Cipla Ltd.
    • 9.4.14. Dr. Reddy's Laboratories Ltd.
    • 9.4.15. Glenmark Pharmaceuticals Ltd.

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!